Cargando…
Ocular side effects of biological agents in oncology: what should the clinician be aware of?
During the last 20 years, biologicals have become increasingly relevant in oncologic therapy. Depending on the medication used, there are different profiles of ocular side effects. Although these can be present in up to 70% of patients, they are generally underreported in the literature. Therefore,...
Autores principales: | Hager, Tobias, Seitz, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878959/ https://www.ncbi.nlm.nih.gov/pubmed/24391443 http://dx.doi.org/10.2147/OTT.S54606 |
Ejemplares similares
-
Linezolid Induced Lactic Acidosis: The Side Effect, Clinician Should Be Aware of
por: Nightingale, Savannah, et al.
Publicado: (2020) -
Molecular biology of high-grade gliomas: what should the clinician know?
por: Hofer, Silvia, et al.
Publicado: (2014) -
Biosimilars in rheumatology: what the clinician should know
por: Castañeda-Hernández, Gilberto, et al.
Publicado: (2015) -
Genetics of ADHD: What Should the Clinician Know?
por: Grimm, Oliver, et al.
Publicado: (2020) -
Apheresis: What Should a Clinician Know?
por: Parhofer, Klaus G.
Publicado: (2023)